NCT00675688View on ClinicalTrials.gov

Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

PHASE3CompletedINTERVENTIONAL

Enrollment

3,544

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Endometrial HyperplasiaOsteoporosis

Interventions

DRUG

Bazedoxifene/Conjugate Estrogens (CE)

DRUG

Raloxifene

DRUG

Placebo

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00675688 - Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women | Biotech Hunter | Biotech Hunter